Trial · NCT07910799
Intraoperative Visualization of Large Head and Neck Tumors to Optimize Radiation Therapy Planning Using Liquid Soft-tissue Markers Such as BioXmark® (During Definitive Treatment or in the Postoperative Setting)
NCT07910799, Not applicable, Not yet recruiting, University Hospital, Essen
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intraoperative Visualization of Large Head and Neck Tumors to Optimize Radiation Therapy Planning Using Liquid Soft-tissue Markers Such as BioXmark® (During Definitive Treatment or in the Postoperative Setting). Trials, record NCT07910799. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910799
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
Intraoperative Visualization of Large Head and Neck Tumors to Optimize Radiation Therapy Planning Using Liquid Soft-tissue Markers Such as BioXmark® (During Definitive Treatment or in the Postoperative Setting)
- NCT number
- NCT07910799
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 295 participants, estimated
- Lead sponsor
- University Hospital, Essen
- Conditions
- Head & Neck Cancer
- Interventions
- tissue marker BioXmark
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Tumor visualization: Assessment of how clearly the tumor and its margins can be identified on medical imaging using BioXmark®. Radiation dose: Assessment of the radiation dose delivered based on the objective imaging and treatment data. Patient-reported | 0-10 years | Objective Data: * Determination of the clinical target volume for radiation planning with and without markers (ml) * Artifact formation (Lickert-scale; 0= none, 1=low, 2=major) Subjective perceptions: * Dysphagia (assessed during treatment visits; established (inter)national questionnaires (H\&N43 (EORTC 0-100 Points), MDADI (20-100 Points)) * Dysphonia (assessed during treatment visits; established (inter)national questionnaires (H\&N43 (EORTC 0-100 Points)) * Quality of life (EQ-5D-5L(0-100 Points) Clinical data (all data are collected as part of routine clinical practice for diagnostic purposes): * Tumor entity: Tumor in the head and neck region with an indication for radiation therapy * Age (years) * Gender (m/f/d) * Staging (TNM categories) * Location * Treatment modalities (Surgery/Chemo/Radiotheorpy/immunotherapy/multiple answere options) * Molecular pathological characteristics of the tumor and its microenvironment (standard of care) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910799
GET https://conductscience.org/api/trials/v1/NCT07910799/registered